Skip to Main content Skip to Navigation
Journal articles

Who are the PLWH who might refuse to participate in HIV cure-related clinical trials with treatment interruption?

Abstract : Achieving a HIV cure has become a research priority. As any improvement of knowledge, which could help scientists design new HIV cure-related clinical trials (HCRCT) depends on the risks potential participants are willing to accept, it is important to understand who will agree or refuse to participate and in which proportions. By providing insights into factors associated with reluctance toward HCRCT participation, our results may help clinicians in patient recruitment.
Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-02547988
Contributor : Isabelle Combe <>
Submitted on : Tuesday, May 18, 2021 - 5:17:27 PM
Last modification on : Wednesday, May 26, 2021 - 3:39:05 AM

File

Protiere C_.pdf
Files produced by the author(s)

Licence


Distributed under a Creative Commons Attribution - NonCommercial 4.0 International License

Identifiers

Collections

Citation

Christel Protière, Marion Fiorentino, Abdourahmane Sow, Marie Préau, Marion Mora, et al.. Who are the PLWH who might refuse to participate in HIV cure-related clinical trials with treatment interruption?. AIDS, Lippincott, Williams & Wilkins, 2020, pp.1. ⟨10.1097/QAD.0000000000002530⟩. ⟨hal-02547988⟩

Share

Metrics

Record views

100

Files downloads

17